3headedmonkey
Gesperrt
Pfizer reibt sich gerade die Hände aufgrund der Impf- und Maskendummheit, die auch in diesem Thread nach der 10. Durchseuchung weiter propagiert wird und die Nachfrage nach ihrem PAXLOVID in die Höhe schießen lässt.
Angela Hwang - Pfizer Inc. - Group President of Biopharmaceuticals Group
So I think when you add all of this up, what we are seeing is the fact that there is demand for this product. We also see that the social -- the removal of the mask mandate, the social distancing requirements that have been removed. You also know that in the EU that just in the last week, they've removed the emergency period of the EUA. That means that people are going to get out there. We know with all of that, infections are going to increase, and that's the role that PAXLOVID can play.
So we're intently focused on working with national governments, state governments, in helping them to educate, to take great lessons learned from around all the different countries to help them to utilize PAXLOVID. And importantly, what we're also seeing is that it's not as -- we don't have any inventory on hand. Every dose that we produce is being shipped out and is being ordered. So I think all of these give us a lot of confidence that there is a demand for PAXLOVID. We know what we need to do to support the utilization of PAXLOVID, and we'll continue to drive that throughout the year as we anticipate further surges in COVID infections.
Angela Hwang - Pfizer Inc. - Group President of Biopharmaceuticals Group
So I think when you add all of this up, what we are seeing is the fact that there is demand for this product. We also see that the social -- the removal of the mask mandate, the social distancing requirements that have been removed. You also know that in the EU that just in the last week, they've removed the emergency period of the EUA. That means that people are going to get out there. We know with all of that, infections are going to increase, and that's the role that PAXLOVID can play.
So we're intently focused on working with national governments, state governments, in helping them to educate, to take great lessons learned from around all the different countries to help them to utilize PAXLOVID. And importantly, what we're also seeing is that it's not as -- we don't have any inventory on hand. Every dose that we produce is being shipped out and is being ordered. So I think all of these give us a lot of confidence that there is a demand for PAXLOVID. We know what we need to do to support the utilization of PAXLOVID, and we'll continue to drive that throughout the year as we anticipate further surges in COVID infections.